Greetings, fiends — I have a tiny little setback to report today. It’s not really a setback, per se, but rather a bump in the road. We shall overcome.
Turns out we will not qualify for the Keytruda study after all. From their site:
Keytruda is a prescription medicine used to treat non–small cell lung cancer (NSCLC). Keytruda may be used as your first treatment option when your lung cancer has spread (advanced NSCLC) and tests positive for “PD-L1” and your tumor does not have an abnormal “EGFR” or “ALK” gene.
Michael meets two of the three requirements. He has advanced NSCLC, and his tumors do not have the abnormal genes. He did, however, test negative for PD-L1. Unfortunately, all three qualifiers must be in place in order to proceed. So, we do full-on chemo. A bit of a bummer, but that’s OK. It doesn’t dilute his resolve, or mine.
We joked a bit over coffee this morning about him losing his hair and the mustache he’s had since 1976. Our grandchildren won’t recognize him. Kidding…everyone will be fine with it. Fellow RtB citizen Stoney recently went through a repeat bout of chemo, and lost her locks. She’s on the rebound now, looking cute with her short, wavy style. I’m sure the Thriller will regrow his handlebar in due time.
Another update: I asked his oncologist if doing treatments in Mansfield would allow him to remain Michael’s primary physician. He said no, that a colleague would take over his care. Not happening. Not that there aren’t good doctors in Mansfield, but this guy is fantastic, and we like and trust him. Hence, we’ll go to Cleveland for treatments. It’s every 20 days or so, and he has his new wheels, so it’s pretty much a no-brainer.
This is the first time Michael has gone to Cleveland without me. I’m kind of ooky about it, but he assured me he will pull over quickly in the event of any coughing/choking fits. (I didn’t go with him today because we couldn’t be sure I’d be back in time for an out-of-town performance at 5 p.m.)
I think that’s it for this morning — thank you again for coming along on this odyssey with us.